arrow
M

Melinda Rezeli

Lund University
H指数:31
被引数:2,796

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative assessment of intratumoral sunitinib distribution and therapeutic response in matched primary and metastatic tumor models

对配对的肿瘤原发灶和转移灶模型中肿瘤内舒尼替尼分布与治疗效果的比较评估

2026-08-220
OAAI
Development of experimental isolated lung perfusion model using surgically resected tumorous human lobes

使用手术切除的肿瘤性人肺叶建立实验性离体肺灌注模型

2026-07-210
OA
Distant metastases of melanoma exhibit varying extent of intrapatient proteogenomic heterogeneity

黑色素瘤的远处转移表现出不同程度的患者内蛋白质组异质性。

2025-09-280
OAAI
Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund Center

具有临床影响的欧洲癌症登月计划隆德中心综合生物样本库策略

2025-05-010
OAAI
Mitochondrial and immune response dysregulation in melanoma recurrence
2023-11-213
OAAI
Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies (vol 15, pg 256, 2020)
2023-05-010
OAAI
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer
2023-03-1422
OA
Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases

脑转移肺腺癌的蛋白质组学分析揭示了肿瘤间异质性和与脑转移时间相关的特定改变

2023-02-018
OAAI
Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function
2023-02-016
PRE
In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer

深入的蛋白质组学分析揭示了人类小细胞肺癌中独特的亚型特异性特征

2022-09-2313
OAAI
Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer

脂质代谢重编程超出了可手术人类胰腺癌的组织学肿瘤界限

2022-09-025
OA